CN113573779A - C10-亚烷基取代的13元大环内酯及其用途 - Google Patents

C10-亚烷基取代的13元大环内酯及其用途 Download PDF

Info

Publication number
CN113573779A
CN113573779A CN201980086676.8A CN201980086676A CN113573779A CN 113573779 A CN113573779 A CN 113573779A CN 201980086676 A CN201980086676 A CN 201980086676A CN 113573779 A CN113573779 A CN 113573779A
Authority
CN
China
Prior art keywords
optionally substituted
alkyl
group
compound
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980086676.8A
Other languages
English (en)
Chinese (zh)
Inventor
R·B·克拉克
R·阿尔姆
W·F·奥斯汀
P·霍根
I·杰维特
S·D·拉希里
J·F·劳伦斯
X·李
S·史
W·王
Y·市川
A·G·迈尔斯
Z·张
P·N·卡尔森
A·桑切斯
G·丹达帕尼
T·尼提帕利
M·A·拉赫曼
T·莱皮特尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ha Folishihui
Zikani Therapeutics Inc
Original Assignee
Ha Folishihui
Zikani Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68916562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN113573779(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ha Folishihui, Zikani Therapeutics Inc filed Critical Ha Folishihui
Publication of CN113573779A publication Critical patent/CN113573779A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN201980086676.8A 2018-11-19 2019-11-18 C10-亚烷基取代的13元大环内酯及其用途 Pending CN113573779A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
US62/769383 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Publications (1)

Publication Number Publication Date
CN113573779A true CN113573779A (zh) 2021-10-29

Family

ID=68916562

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980086676.8A Pending CN113573779A (zh) 2018-11-19 2019-11-18 C10-亚烷基取代的13元大环内酯及其用途

Country Status (22)

Country Link
US (1) US12552825B2 (cg-RX-API-DMAC10.html)
EP (2) EP4737470A3 (cg-RX-API-DMAC10.html)
JP (2) JP7551610B2 (cg-RX-API-DMAC10.html)
KR (1) KR102929869B1 (cg-RX-API-DMAC10.html)
CN (1) CN113573779A (cg-RX-API-DMAC10.html)
AU (1) AU2019385333B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009624A2 (cg-RX-API-DMAC10.html)
CA (1) CA3120148A1 (cg-RX-API-DMAC10.html)
DK (1) DK3883647T3 (cg-RX-API-DMAC10.html)
ES (1) ES3063764T3 (cg-RX-API-DMAC10.html)
FI (1) FI3883647T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260395T1 (cg-RX-API-DMAC10.html)
IL (1) IL283194B2 (cg-RX-API-DMAC10.html)
LT (1) LT3883647T (cg-RX-API-DMAC10.html)
MX (1) MX2021005423A (cg-RX-API-DMAC10.html)
PL (1) PL3883647T3 (cg-RX-API-DMAC10.html)
PT (1) PT3883647T (cg-RX-API-DMAC10.html)
RS (1) RS68104B1 (cg-RX-API-DMAC10.html)
SG (1) SG11202105227QA (cg-RX-API-DMAC10.html)
SI (1) SI3883647T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202600094T1 (cg-RX-API-DMAC10.html)
WO (1) WO2020106627A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
JP2025530776A (ja) 2022-09-01 2025-09-17 ジカニ セラピューティクス, インコーポレイテッド 13員環マクロライドを使用した家族性大腸腺腫症の処置

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000031097A1 (en) * 1998-11-20 2000-06-02 Pfizer Products Inc. 13-membered azalides and their use as antibiotic agents
CN1301268A (zh) * 1998-04-06 2001-06-27 普利瓦药物工业公司 抗细菌活性的15元内酰胺类酮内酯
CN1429232A (zh) * 2000-04-27 2003-07-09 辉瑞产品公司 氮杂大环内酯抗生素组合物在治疗或预防哺乳动物细菌或原生动物感染中的应用
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
CN1788013A (zh) * 2003-05-14 2006-06-14 普利瓦研究院有限公司 新的9-脱氧-9-二氢-9A-氮杂-9A-高红霉素A的3-去红霉糖基9a-N-氨基甲酰基和9a-N-硫代氨基甲酰基衍生物
CN101228171A (zh) * 2005-07-26 2008-07-23 默克勒有限公司 作为5-脂氧化酶和环加氧酶抑制剂的吡咯里嗪和中氮茚化合物的大环内酯偶联物
EP1985620A1 (en) * 2006-02-07 2008-10-29 Taisho Pharmaceutical Co., Ltd 10a-AZALIDE COMPOUND
WO2012001089A1 (en) * 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions
CN102993250A (zh) * 2011-07-06 2013-03-27 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN107530365A (zh) * 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途
US20180273573A1 (en) * 2015-10-01 2018-09-27 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2018201076A2 (en) * 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
EP3277701A4 (en) 2015-03-25 2019-03-06 President and Fellows of Harvard College SYNTHESIS OF DESOSAMINES

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301268A (zh) * 1998-04-06 2001-06-27 普利瓦药物工业公司 抗细菌活性的15元内酰胺类酮内酯
CN101367853A (zh) * 1998-11-20 2009-02-18 辉瑞产品公司 十三元氮杂大环内酯类化合物及其作为抗生剂的应用
WO2000031097A1 (en) * 1998-11-20 2000-06-02 Pfizer Products Inc. 13-membered azalides and their use as antibiotic agents
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
CN1429232A (zh) * 2000-04-27 2003-07-09 辉瑞产品公司 氮杂大环内酯抗生素组合物在治疗或预防哺乳动物细菌或原生动物感染中的应用
CN1788013A (zh) * 2003-05-14 2006-06-14 普利瓦研究院有限公司 新的9-脱氧-9-二氢-9A-氮杂-9A-高红霉素A的3-去红霉糖基9a-N-氨基甲酰基和9a-N-硫代氨基甲酰基衍生物
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
CN101228171A (zh) * 2005-07-26 2008-07-23 默克勒有限公司 作为5-脂氧化酶和环加氧酶抑制剂的吡咯里嗪和中氮茚化合物的大环内酯偶联物
EP1985620A1 (en) * 2006-02-07 2008-10-29 Taisho Pharmaceutical Co., Ltd 10a-AZALIDE COMPOUND
WO2012001089A1 (en) * 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions
CN102993250A (zh) * 2011-07-06 2013-03-27 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN107530365A (zh) * 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途
US20180273573A1 (en) * 2015-10-01 2018-09-27 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2018201076A2 (en) * 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张晓曦: "酮内酯抗生素结构修饰的研究进展", 《药学学报》, vol. 53, no. 6, pages 852 *

Also Published As

Publication number Publication date
IL283194B1 (en) 2024-11-01
EP3883647B1 (en) 2026-02-11
SMT202600094T1 (it) 2026-03-09
RS68104B1 (sr) 2026-06-30
SI3883647T1 (sl) 2026-04-30
MX2021005423A (es) 2021-09-08
IL283194A (en) 2021-06-30
JP7551610B2 (ja) 2024-09-17
IL283194B2 (en) 2025-03-01
FI3883647T3 (fi) 2026-03-25
JP2025000636A (ja) 2025-01-07
EP4737470A3 (en) 2026-07-22
PT3883647T (pt) 2026-02-26
DK3883647T3 (da) 2026-03-23
SG11202105227QA (en) 2021-06-29
PL3883647T3 (pl) 2026-06-01
US12552825B2 (en) 2026-02-17
EP4737470A2 (en) 2026-05-06
JP2022507776A (ja) 2022-01-18
AU2019385333B2 (en) 2025-04-17
LT3883647T (lt) 2026-03-25
HRP20260395T1 (hr) 2026-05-08
EP3883647A1 (en) 2021-09-29
KR20210133950A (ko) 2021-11-08
CA3120148A1 (en) 2020-05-28
US20230093692A1 (en) 2023-03-23
WO2020106627A1 (en) 2020-05-28
ES3063764T3 (en) 2026-04-20
BR112021009624A2 (pt) 2021-08-10
KR102929869B1 (ko) 2026-02-23
AU2019385333A1 (en) 2021-07-01

Similar Documents

Publication Publication Date Title
US11535643B2 (en) Macrolides with modified desosamine sugars and uses thereof
US20260035402A1 (en) C10-alkylene substituted 13-membered macrolides and uses thereof
AU2023229518A1 (en) C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof
JP2025000636A (ja) C10-アルキレン置換された13員マクロライド及びそれらの使用
JP7210540B2 (ja) 血漿カリクレインの阻害剤およびその使用
US20170305953A1 (en) 14-membered ketolides and methods of their preparation and use
US20230203081A1 (en) Lincosamide antibiotics and uses thereof
US20230242565A1 (en) Macrolides with Modified Desosamine Sugars and Uses Thereof
HK40063248A (en) C10-alkylene substituted 13-membered macrolides and uses thereof
HK40063711A (en) C11-cyclic substituted 13-membered macrolides and uses thereof
BR122025025362A2 (pt) Macrolídeos com 13 membros substituídos por c10-alquileno e usos dos mesmos
EA052403B1 (ru) C10-алкилен-замещенные 13-членные макролиды и их применение

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40063248

Country of ref document: HK